Pharmaceutical company Merz North America announced Wednesday that it would shift its headquarters from Greensboro to Raleigh and consolidate other operations in the Triangle.
The moves will bring 250 jobs to Raleigh, including 50 that weren’t already in North Carolina, officials said.
“For Merz, this move accelerates us toward our vision of becoming the world’s most admired, trusted and innovative aesthetics and neurotoxin company,” Merz North America President and Chief Executive Bill Humphries said in a statement. “Our focus is on offering best-in-class customer service, bringing continued innovation to the marketplace and forging new partnerships.”
The company focuses on medicines in the areas of dermatology, neurology and metabolic disorders, including a one to treat moderate to severe Alzheimer’s dementia.
Merz officials studied cities in several states over the last year as they considered how best to consolidate operations. They said they were attracted to Raleigh because the nearby research universities, two of which have dermatology and neurology teaching programs; an educated workforce; and the proximity of Raleigh-Durham International Airport, which is trying to land a direct flight to Frankfurt, Germany, the location of Merz Pharma Group’s global headquarters.
“With more state-of-the-art space, our core business functions in one place and easy access to the brightest minds in the industry, Raleigh provides the best option for our future growth,” Humphries said. “We are pleased to join the area as we evolve to become an even more significant player in our industry.”
The move will come in stages, and Merz has already leased 60,000 square feet in a Six Forks Road office building to meet the company’s needs as its consolidates.
